Cancer News

Leukemia – Multiple Myeloma Research News: AGGRESSIVE FORM OF LEUKEMIA LINKED TO DEFECTIVE ‘PROTEIN FACTORY’

Posted on
Health Medical Breakthroughs Treatment

(SOURCE: KU LEUVEN) – Twenty to forty percent of the patients with the type of leukaemia known as multiple myeloma have a defect in the ‘protein factory’ of the cell: the ribosome. These patients have a poorer prognosis than patients with intact ribosomes. At the same time, they respond better to a drug that already exists. These are the findings […]

Cancer News

Multiple Myeloma Research News: Early treatment may prevent progression to multiple myeloma

Posted on
Health Medical Breakthroughs Treatment

(SOURCE: DANA-FARBER CANCER INSTITUTE) – Early intervention with an immunotherapy-based drug combination may prevent progression of high-risk “smoldering” multiple myeloma to the full-blown disease, according to researchers from Dana-Farber Cancer Institute. The interim results of a phase 2 clinical trial are to be presented at the 58th annual meeting of the American Society of Hematology in […]

Cancer News

Multiple Myeloma Research News: Additions to Standard Multiple Myeloma Therapy Do Not Appear to Yield Additional Benefit

Posted on
Health Medical Breakthroughs Treatment

(SOURCE: AMERICAN SOCIETY OF HEMATOLOGY) – Largest randomized trial finds second round of chemotherapy or stem cell transplant does not improve progression-free survival. Trial results being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego suggest two therapies that are often added to standard therapy in patients with multiple myeloma […]

Cancer News

Highlights include first results of multisite trial of CTL019 for pediatric acute lymphoblastic leukemia and new CAR T cell therapy for multiple myeloma

Posted on
Health Medical Breakthroughs Treatment

(SOURCE: UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE) Lymphoma and Multiple Lyeloma Research News – Researchers from the Perelman School of Medicine at the University of Pennsylvania and The Children’s Hospital of Philadelphia (CHOP) will present the latest advances from their studies of personalized cellular therapies for blood cancers during the 58th Annual Meeting of the American […]

Cancer News

Multiple Myeloma Treatment News: Mayo Clinic study shows that choice of medical center impacts life expectancy of multiple myeloma patients

Posted on
Health Medical Breakthroughs Treatment

(SOURCE: MAYO CLINIC) People diagnosed with multiple myeloma are more likely to live longer if they are treated at a medical center that sees many patients with this blood cancer. Mayo Clinic researchers published these findings today in the Journal of Clinical Oncology. Multiple myeloma is a rare form of blood cancer that attacks plasma cells […]

Cancer News

Experimental Immunotherapy Galinpepimut-S May Benefit Multiple Myeloma Patients

Posted on
Health Medical Breakthroughs Treatment

(Myeloma Research News) According to a recent article published Myeloma Research News, patients with high-risk multiple myeloma may benefit from an experimental immunotherapy from SELLAS Life Sciences called galinpepimut-S, following an autologous stem cell transplant (ASCT). The data was gathered from a Phase 2 clinical trial which shows that the agent nearly doubles the progression-free survival rates […]

Cancer News

Essential Amino Acid Found to Play Key Role in Creation of Blood Stem Cells

Posted on
Health Medical Breakthroughs Treatment

(Scientific American) According to an article recently published in Scientific American, a team of researchers from California and Japan has found that an essential amino acid plays a crucial role in the creation of blood stem cells. This type of discovery the scientists say could offer a potential alternative to chemotherapy and radiation in treating […]

Cancer News

S63845 Compound a Possible Breakthrough in Blood Cancer Research

Posted on
Health Medical Breakthroughs Treatment

(SBS Australia) According to an article recently published on SBS, a team of international researchers at Australia’s Walter and Eliza Hall Institute have made a “major scientific breakthrough” in cancer research that has the potential to help millions of people with the deadly disease.

Cancer News

Top-Line Results From Amgen Phase 3 KYPROLIS® (Carfilzomib) CLARION Multiple Myeloma Study

Posted on
Health Medical Breakthroughs Treatment

(PR Newswires) Amgen recently announced top-line results of the Phase 3 CLARION trial, which evaluated an investigational regimen of KYPROLIS® (carfilzomib), melphalan and prednisone (KMP) versus Velcade® (bortezomib), melphalan and prednisone (VMP) for 54 weeks in patients with newly diagnosed multiple myeloma who were ineligible for hematopoietic stem-cell transplant. The trial did not meet the primary endpoint of […]